首页> 外国专利> A METHOD FOR DETECTION OF LIVER CANCER, RISK OF LIVER CANCER, RISK OF RECURRENCE OF LIVER CANCER, MALIGNANCY OF LIVER CANCER AND PROGRESSION OF LIVER CANCER WITH TIME BY USING THEMETHYLATED CYTOSINE IN BASP1 GENE AND/OR SRD5A2 GENE

A METHOD FOR DETECTION OF LIVER CANCER, RISK OF LIVER CANCER, RISK OF RECURRENCE OF LIVER CANCER, MALIGNANCY OF LIVER CANCER AND PROGRESSION OF LIVER CANCER WITH TIME BY USING THEMETHYLATED CYTOSINE IN BASP1 GENE AND/OR SRD5A2 GENE

机译:通过使用BASP1基因和/或SRD5A2基因中的甲基化胞嘧啶来检测肝癌,肝癌的风险,肝癌复发的风险,肝癌的恶性和肝癌随时间进展的方法

摘要

The present invention provides a novel method for detection of liver cancer. This method detects high-sensitively, high-specifically, simply and accurately liver cancer, especially that in early stage by identifying and/or quantifying methylation on particular genes and/or their DNA fragments in clinical specimens, and by combining said methylated DNA values with existing tumor marker values and/or DNA amounts in blood. This invention also detects a precancerous lesion, detects a risk of recurrence after treatment of liver cancer, detects malignancy of liver cancer and monitors progression of liver cancer with time by the same method. As for particular genes, BASPl gene, SPINT2 gene, APC gene, CCND2 gene, CFTR gene, RASSFl gene and SRD5A2 gene are mentioned.
机译:本发明提供了一种检测肝癌的新方法。该方法可通过识别和/或定量临床样本中特定基因和/或其DNA片段上的甲基化并结合所述甲基化DNA值和高灵敏度,高特异性,简单而准确地检测肝癌,尤其是在早期阶段。血液中现有的肿瘤标志物值和/或DNA量。本发明还检测癌前病变,检测肝癌治疗后的复发风险,检测肝癌的恶性,并通过相同的方法随时间监测肝癌的进展。至于特定的基因,提到了BASP1基因,SPINT2基因,APC基因,CCND2基因,CFTR基因,RASSF1基因和SRD5A2基因。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号